Neogen Corporation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Neogen Corporation shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2022-02-28 was 26.00K shares, a 93.26% decline year-over-year.
- Neogen Corporation shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2021-11-30 was 275.00K shares, a 32.27% decline year-over-year.
- Neogen Corporation shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2021-08-31 was 6.00K shares, a 96.51% decline year-over-year.
- Neogen Corporation shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2021-02-28 was 386.00K shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 12 month |
|---|---|---|
| 2022-02-28 | 26.00K shares 10-Q · filed 2022-04-01 | |
| 2021-11-30 | 275.00K shares 10-Q · filed 2022-04-01 | |
| 2021-08-31 | 6.00K shares 10-Q · filed 2022-04-01 | |
| 2021-02-28 | 386.00K shares 10-Q · filed 2022-04-01 | |
| 2020-11-30 | 406.00K shares 10-Q · filed 2022-04-01 | |
| 2020-08-31 | 172.00K shares 10-Q · filed 2022-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |